Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

Summary

Effects of AT1 receptor antagonist telmisartan on the primary endpoint inflammatory parameters in patients with coronary artery disease (CAD). Secondary endpoints are alterations in clinical course and blood pressure

Timeline

Start

2001-12

Primary completion

2004-03

Completion

2004-05

Drugs

Indications